Latest stories on RPRX
Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
The Motley Fool57 · neutralgeneral
3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
The Motley Fool63 · neutralanalyst
Royalty Pharma declares $0.235 dividend
Seeking Alpha56 · neutralgeneral
Royalty Pharma declares fourth quarter 2026 dividend
StockTitan52 · neutralgeneral
Royalty Pharma declares fourth quarter 2026 dividend
GlobeNewswire53 · neutralgeneral
Repay Holdings announces partnership with Emburse
The Fly61 · neutralproduct/pr
Royalty Pharma (RPRX) Offers Attractive Risk-Reward Profiles at Reasonable Multiples
Yahoo Finance63 · neutralanalyst
Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
Business Insider50 · neutralearnings
Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
GlobeNewswire50 · neutralearnings
Royalty Pharma price target raised to $67 from $65 at Morgan Stanley
The Fly61 · neutralanalyst
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
The Motley Fool67 · bullishanalyst
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
The Motley Fool57 · neutralanalyst
Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program
GlobeNewswire58 · neutralgeneral
Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program
Business Insider50 · neutralgeneral
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
PR Newswire63 · neutralgeneral
Royalty Pharma plc (RPRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha55 · neutralgeneral
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure?
Yahoo Top34 · bearishproduct/pr
Royalty Pharma to present at upcoming investor conferences
GlobeNewswire56 · neutralgeneral
Royalty Pharma to present at upcoming investor conferences
Business Insider56 · neutralgeneral
EQS-News: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma
Business Insider67 · bullishgeneral
EQS-Adhoc: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma
Business Insider67 · bullishproduct/pr
TD Cowen raises Royalty Pharma stock price target on unchanged growth outlook
Investing.com Analyst Ratings61 · neutralanalyst
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
GlobeNewswire67 · bullishproduct/pr
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
StockTitan67 · bullishproduct/pr